Idexx drops Schein

|By:, SA News Editor

Idexx Laboratories (NASDAQ:IDXX) informs distributor Henry Schein (NASDAQ:HSIC) that it intends to sell its vet diagnostic products directly in the U.S. effective January 1, 2015. This will eliminate ~$150M in top line sales for Schein and $0.04 - 0.06 in EPS. The company does not forecast a negative impact on 2014 results, however, because it will pick up other brands to sell in the meantime.